MAR 11, 2018 9:39 PM PDT

New Drug for Multiple Sclerosis? Potential Therapeutic Treatment Uncovered

WRITTEN BY: Nouran Amin

Multiple sclerosis (MS) is a neurological disease that is unpredictable and often disabling in affected individuals. It is more specifically a disease of the central nervous system (CNS) that afflicts the transport of information in the brain, and how this information is being transmitted to the rest of the body.

 

Unfortunately, there is currently no cure for MS; however, recent research at Mainz University Medical Center in collaboration with the University of Montreal has proposed a new treatment. The researchers experimented in model mice using endothelial cells and discovered that a protein known as EGFL7 hinders the transportation of immune cells into the CNS by maintaining the blood-brain barrier.

The research team leaders are Dr. Timo Uphaus and Professor Frauke Zipp of the Department of Neurology at the University Medical Center of Johannes Gutenberg University Mainz in collaboration with Dr. Catherine Larochelle of the University of Montreal and Professor Mirko Schmidt as well as researchers of the German Cancer Consortium (DKTK). The purpose of the research study is to develop a drug treatment that will stop the pathology of MS from progressing. The focus was the molecule EGFL7 and its role in cell migration MS.

EGFL7 is released into the blood-brain barrier by endothelial cells. In breast cancer, EGFL7 was examined not to have an influence on cellular migration to tumor tissue. For MS, the significance of immune cells is its migration to the brain; this motivated researchers to investigate the relationship between cell migration and the protein EGFL7, and later to propose a treatment for MS.

Investigators discovered that inflammation in the central nervous system was due to increased levels of EGFL7. Since immune cells bind to EGFL7, the protein cannot cross into the central nervous system. When EGFL7 is released, the immune cells are retained in the perivascular space. In model trials, the investigators found that exposure to the protein made the blood-brain barrier less permeable. Additionally, the transportation of immune cells into the central nervous system was reduced.

These discoveries opposed the pathological characteristics of MS and improved the clinical symptoms. The findings concluded that in a human blood-brain barrier model, the migration of immune cells was greatly reduced in isolated endothelial cells. Researchers believe that it may be possible to use EGFL7’s inhibiting properties on migrating immune cells as well as the proteins ability to enhance the impenetrability of the blood-brain barrier. Overall, the results illustrate how EGFL7 can limit CNS immune cell invasion encouraging a potential drug development that involves EGFL7 agonist in the treatment of MS.

The research study was published in Nature Communications.

Sources: Nature Communications, Drug Target Review, National MS Society

 

 

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 16, 2022
Neuroscience
A New Approach to Seizure Treatment
APR 16, 2022
A New Approach to Seizure Treatment
There are many types of epilepsy, a brain disorder that causes recurrent seizures or periods of altered behaviors or sen ...
APR 25, 2022
Microbiology
How a Serious Infection Can Cause Mood Disorders
APR 25, 2022
How a Serious Infection Can Cause Mood Disorders
When a pathogen invades the body, the immune system has to mount a response, which involves inflammation. But inflammati ...
JUN 08, 2022
Coronavirus
How are you Preparing for the Next Covid Surge?
JUN 08, 2022
How are you Preparing for the Next Covid Surge?
After two years of uncertainty, we can definitely say that the coronavirus (Covid-19) has changed our everyday lives as ...
JUN 26, 2022
Drug Discovery & Development
Vitamin Supplements are a 'Waste of Money' for Healthy Americans
JUN 26, 2022
Vitamin Supplements are a 'Waste of Money' for Healthy Americans
The US Preventive Services Task Force (USPSTF) recommends against using beta carotene or vitamin E supplements to preven ...
JUN 27, 2022
Drug Discovery & Development
Potential Gene Targets Identified for Treating Deafness
JUN 27, 2022
Potential Gene Targets Identified for Treating Deafness
Researchers have identified three mutations of the MINAR2 gene that are linked to deafness. They say that the mutations ...
JUN 29, 2022
Microbiology
Unleashing the Genetic Power of Ocean Microbes
JUN 29, 2022
Unleashing the Genetic Power of Ocean Microbes
By analyzing over 1,000 samples of the marine environment, researchers have reconstructed the genomes of 25,000 novel mi ...
Loading Comments...